Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study
Titel:
Oral MEK 1/2 Inhibitor Trametinib in Combination With AKT Inhibitor GSK2141795 in Patients With Acute Myeloid Leukemia With RAS Mutations: A Phase II Study
Auteur:
Ragon, Brittany Knick Odenike, Olatoyosi Baer, Maria R. Stock, Wendy Borthakur, Gautam Patel, Keyur Han, Lina Chen, Helen Ma, Helen Joseph, Loren Zhao, Yang Baggerly, Keith Konopleva, Marina Jain, Nitin